Smethwick-based Rem3dy Health secures £500k from Future Planet Capital Regional
At a glance
This article covers a SAFE round on 24 September 2025 for Rem3dy Health, a Midlands-based healthtech company founded by Melissa Snover. The round raised £500k, led by Future Planet Capital Regional with backing from the West Midlands Co-Investment Fund.
What does Rem3dy Health do?
Nourished offers personalised, 3D-printed nutrient gummies made with patented technology and natural vegan ingredients. They provide tailored daily vitamin doses in seven-layer stacks for individual nutritional needs.
Why is Rem3dy Health useful?
Problem
People want personalised, convenient health and wellness solutions but traditional vitamins often fall short. Pills, synthetic ingredients and plastic packaging fail to meet individual diets or sustainability concerns.
Solution
Rem3dy Health explains that it creates personalised, seven-layer nutrient gummies using patented 3D printing technology. The gummies use natural, food-derived ingredients and replace multiple pills while reducing synthetic additives and plastic waste.
How much did Rem3dy Health raise?
Rem3dy Health raised a £500k SAFE from Future Planet Capital Regional via the West Midlands Co-Investment Fund, as part of a £9m total raise. This makes it the 48th largest funding round in September 2025 (48 recorded). It ranks 421st of the year (455 recorded) in the Startupmag database, as of 24 September 2025.
For details on how Startupmag compiles its rankings, view our Methodology.
Who invested in Rem3dy Health?
Key investors in the deal include the following organisations and corporate backers:
- West Midlands Co-Investment Fund: A regional co-investment fund that provides equity to innovative SMEs in the West Midlands alongside private co-investors. Its portfolio includes Inicio AI and Get Well Soon.
- Future Planet Capital Regional: A Midlands-based venture capital firm that invests in SMEs across the West Midlands and manages regional co-investment funds.
- Suntory: A Japanese multinational in beverages and consumer goods with interests in consumer health and nutrition investments.
- ADM: A global agri-food and ingredients company that invests across food, nutrition and ingredient supply chains.
- UPSA: A pharmaceutical company focused on consumer healthcare and medicines.
In the funding announcement, Rupert Lyle from Future Planet Capital Regional said:
We have known Melissa Snover for several years and are incredibly impressed by her dedication to the West Midlands. Her desire to have a local investor on her cap table, coupled with the groundbreaking technology Rem3dy Health is developing, made this an unmissable opportunity.
The investor said the company offers a more effective and user-friendly way to consume vitamins and that using natural, food-derived materials without artificial additives makes the products safer and healthier for consumers, aligning with the fund’s commitment to supporting innovative and impactful businesses.
If you're researching potential backers in this space:
- Explore our list of Healthtech venture capital firms in the UK
- Browse our directory of Healthtech angel investors in the UK
Who founded Rem3dy Health?
Melissa Snover is the founder of Rem3dy Health.
In the funding announcement, Melissa Snover said:
Securing this investment from Future Planet Capital Regional and the West Midlands Co-Investment Fund is a significant milestone for Rem3dy Health. It’s particularly meaningful to have a strong West Midlands investor join us, further cementing our roots in this dynamic region.
The company continued that the funding would be used to scale its manufacturing capabilities and expand its global reach to provide personalised and sustainable health solutions.
Where is Rem3dy Health based?
Rem3dy Health is based in Smethwick, UK.
What sector is Rem3dy Health in?
Rem3dy Health operates in the healthtech sector. Healthtech uses technology to improve healthcare products, services and delivery. In plain terms, it builds digital tools and devices to help people manage and improve health.
Key trends and challenges in Healthtech:
Personalised consumer health products
Consumers prefer tailored supplements and apps, for example custom nutrient packs based on questionnaires or DNA tests.
Manufacturing scale-up and regulatory compliance
Novel product formats need scaled manufacturing and strict quality rules, such as GMP certification for supplement factories.
Clinical evidence and data protection
Healthtech must provide clinical proof and protect patient data, for example trials and GDPR compliant data handling.
For a deeper look at innovation in this space, see the latest funded Healthtech startups in the UK
They've invested in Rem3dy Health
Get to know these Healthtech investors
Click here for a full list of 7,233+ startup investors in the UK